Literature DB >> 23015724

Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.

Judith Verhelst1, Eef Parthoens, Bert Schepens, Walter Fiers, Xavier Saelens.   

Abstract

Mx1 is a GTPase that is part of the antiviral response induced by type I and type III interferons in the infected host. It inhibits influenza virus infection by blocking viral transcription and replication, but the molecular mechanism is not known. Polymerase basic protein 2 (PB2) and nucleoprotein (NP) were suggested to be the possible target of Mx1, but a direct interaction between Mx1 and any of the viral proteins has not been reported. We investigated the interplay between Mx1, NP, and PB2 to identify the mechanism of Mx1's antiviral activity. We found that Mx1 inhibits the PB2-NP interaction, and the strength of this inhibition correlated with a decrease in viral polymerase activity. Inhibition of the PB2-NP interaction is an active process requiring enzymatically active Mx1. We also demonstrate that Mx1 interacts with the viral proteins NP and PB2, which indicates that Mx1 protein has a direct effect on the viral ribonucleoprotein complex. In a minireplicon system, avian-like NP from swine virus isolates was more sensitive to inhibition by murine Mx1 than NP from human influenza A virus isolates. Likewise, murine Mx1 displaced avian NP from the viral ribonucleoprotein complex more easily than human NP. The stronger resistance of the A/H1N1 pandemic 2009 virus against Mx1 also correlated with reduced inhibition of the PB2-NP interaction. Our findings support a model in which Mx1 interacts with the influenza ribonucleoprotein complex and interferes with its assembly by disturbing the PB2-NP interaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015724      PMCID: PMC3503048          DOI: 10.1128/JVI.01682-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis.

Authors:  Fumitaka Momose; Tadasuke Naito; Keiichi Yano; Seiji Sugimoto; Yuko Morikawa; Kyosuke Nagata
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

2.  THE RESISTANCE OF A2G MICE TO MYXOVIRUSES.

Authors:  J LINDENMANN; C A LANE; D HOBSON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

3.  Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB.

Authors:  Megan C King; Graça Raposo; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

4.  The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

5.  Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

6.  Combined action of mouse alpha and beta interferons in influenza virus-infected macrophages carrying the resistance gene Mx.

Authors:  T Meyer; M A Horisberger
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Interferon-dependent genetic resistance to influenza virus in mice: virus replication in macrophages is inhibited at an early step.

Authors:  M A Horisberger; O Haller; H Arnheiter
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

8.  Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product.

Authors:  R M Krug; M Shaw; B Broni; G Shapiro; O Haller
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Mx1 gene protects mice against the highly lethal human H5N1 influenza virus.

Authors:  Rachelle Salomon; Peter Staeheli; Georg Kochs; Hui-Ling Yen; John Franks; Jerold E Rehg; Robert G Webster; Erich Hoffmann
Journal:  Cell Cycle       Date:  2007-07-22       Impact factor: 4.534

10.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

View more
  90 in total

1.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

Review 2.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  West Nile Virus-Inclusive Single-Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response within Single Cells.

Authors:  Justin T O'Neal; Amit A Upadhyay; Amber Wolabaugh; Nirav B Patel; Steven E Bosinger; Mehul S Suthar
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein.

Authors:  Judith Verhelst; Dorien De Vlieger; Xavier Saelens
Journal:  J Vis Exp       Date:  2015-04-21       Impact factor: 1.355

5.  Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition.

Authors:  Thomas H Oguin; Shalini Sharma; Amanda D Stuart; Susu Duan; Sarah A Scott; Carrie K Jones; J Scott Daniels; Craig W Lindsley; Paul G Thomas; H Alex Brown
Journal:  J Biol Chem       Date:  2014-07-27       Impact factor: 5.157

6.  Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.

Authors:  Judith Verhelst; Jan Spitaels; Cindy Nürnberger; Dorien De Vlieger; Tine Ysenbaert; Peter Staeheli; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

7.  Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.

Authors:  Darren Wethington; Olivia Harder; Karthik Uppulury; William C L Stewart; Phylip Chen; Tiffany King; Susan D Reynolds; Alan S Perelson; Mark E Peeples; Stefan Niewiesk; Jayajit Das
Journal:  J R Soc Interface       Date:  2019-11-27       Impact factor: 4.118

Review 8.  To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.

Authors:  Michaela Weber-Gerlach; Friedemann Weber
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus.

Authors:  Corinna Patzina; Otto Haller; Georg Kochs
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

10.  Influenza Virus Susceptibility of Wild-Derived CAST/EiJ Mice Results from Two Amino Acid Changes in the MX1 Restriction Factor.

Authors:  Cindy Nürnberger; Vanessa Zimmermann; Melanie Gerhardt; Peter Staeheli
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.